ARATANA THERAPEUTICS, INC. — Form D

ARATANA THERAPEUTICS, INC. of KANSAS CITY, KS, a company, filed a Form D exempt-offering notice with the SEC on 2011-10-25. The offering totals $15.5M. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ron MeeusenDirectorEmeryville, CA
David RosenExecutive OfficerNew York, NY
Jay LichterDirectorLa Jolla, CA
Jay LichterExecutive OfficerLa Jolla, CA
Jay Lichter, Ph.D.DirectorLa Jolla, CA
Jay Lichter, Ph.D.Executive OfficerLa Jolla, CA
Linda RhodesDirectorSan Francisco, CA
Linda RhodesExecutive OfficerSan Francisco, CA
Craig ToomanDirectorLondon, X0
Robert GerberDirectorCARLSBAD, CA
Ernst A Heinen, D.V.M., Ph.D.Executive OfficerKansas City, KS
Steven L St. Peter, M.D.DirectorKansas City, KS
Steven L St. Peter, M.D.Executive OfficerKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.DirectorKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.Executive OfficerKansas City, KS
Ronald L Meeusen, Ph.D.DirectorBurr Ridge, IL
Louise A MawhinneyExecutive OfficerKansas City, KS
Craig L ToomanDirectorFar Hills, NJ
John L Vander VortDirectorBoston, MA
Julia A StephanusExecutive OfficerKansas City, KS
John Vander VortDirectorKansas City, KS
Steven St. PeterDirectorKansas City, KS
Steven St. PeterExecutive OfficerKansas City, KS
Ronald L. MeeusenDirectorKansas City, KS
Rip GerberDirectorKansas City, KS

Other filings by this issuer (3)

FiledFormOfferingSold
2013-10-23D$29.8M$29.8M
2012-12-28D$12.0M
2011-01-07D$20.0M$10.0M

More